TY  - JOUR

T1  - A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial

JO  - Journal of Thoracic Oncology

PY  - 2020/10/01

AU  - Peters S

AU  - Danson S

AU  - Hasan B

AU  - Dafni U

AU  - Reinmuth N

AU  - Majem M

AU  - Tournoy KG

AU  - Mark MT

AU  - Pless M

AU  - Cobo M

AU  - Rodriguez-Abreu D et al

ED  - 

DO  - DOI: 10.1016/j.jtho.2020.06.011

PB  - Elsevier

VL  - 15

IS  - 10

SP  - 1647

EP  - 1656

Y2  - 2025/12/07

ER  -